Insights from virologist Erin Sorrell PhD MSc offer perspectives on prevention and response strategies.
In late March 2024, a dairy farm worker in Texas reported symptoms including redness and discomfort in the right eye. Both conjunctival and nasopharyngeal swab specimens from the worker tested positive for influenza A, specifically A(H5) virus, with subsequent confirmation by the CDC for HPAI A(H5N1) virus.1
Erin Sorrell PhD MSc holds a master’s in virology and is a Senior Scholar at the Center for Health Security at Johns Hopkins. She is a faculty member in the Department of Environmental Health and Engineering at the Bloomberg School of Public Health.
“We need to understand and assess the different types of exposure risks that our agricultural workforce comes into contact with daily, and create better evidence-based approaches to their protection, whether that's through education and advocacy or physical equipment, like personal protective equipment, like goggles, gloves, boots, when those are necessary and when those may not be necessary,” according to Sorrell. “He did not have goggles on so that could have been either transmission where there might have been infected milk on his hands, he rubbed his face and it got into his eyes that way.”
The genomic analysis identified the virus as belonging to clade 2.3.4.4b (genotype B3.13), consistent with strains circulating in Texas dairy cattle and peridomestic wild birds. The virus exhibited a genetic mutation (PB2 E627K) associated with enhanced adaptation to mammalian hosts.
“The stress should be beyond this outbreak is thinking about improved occupational health and safety for agricultural workers, because this scenario could happen again,” according to Sorrell. “We really need to be able to not only respond to the current situation but adapt and prevent future exposure risks.”
The infected worker was isolated, and antiviral treatment with oseltamivir was initiated. Existing candidate vaccine viruses closely match the hemagglutinin of the circulating strain, providing a potential avenue for vaccine development should the need arise.
Transmission and Exposure:
Prevention Measures:
Monitoring and Management:
Clinical Management:
Occupational Safety:
Public Health Response: